Interview with John Norman, Country Manager, Nycomed South Africa
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
Address: 1 Libertas Road
Cnr Main Road and Sloane Street
Bryanston, Johannesburg
2191,South Africa
Tel: +27 (0) 11 514 3000
Web: http://www.takeda.co.za/za/
The South African arm of Nycomed has its origins in 1996 when two German companies, Byk Gulden and Madaus AG entered into a joint venture in South Africa and Byk Madaus was created. All products were managed in one combined portfolio and came from either Byk Gulden, Madaus or were in-licenced from other companies. Packaging, warehousing and distribution operations were carried out at a warehouse facility in Midrand.
In 2001, the company outsourced its distribution to PHD.
In 2002, Altana Pharma was launched when Altana bought out the Byk portion of the Byk Madaus joint venture.
In 2003 a further name change took place and the company became the South African joint venture known as Altana Madaus. It was during this period that a separate OTC and Rx division were launched, the Midrand facility was sold and the company moved from Midrand to Woodmead.
In 2007 Nycomed GmbH acquired Altana Pharma and Rottapharm acquired Madaus GmbH. A further name change took place and the local company became known as Nycomed Madaus.
In 2008, Nycomed GmbH acquired the Madaus 50% share of the joint venture and the South African business now falls under the sole control of the Nycomed group of companies.
The South African product range encompasses both licensed and in-licensed OTC (Over the Counter) and Rx (prescription) products. These products are marketed and distributed nationally.
The Rx* product range covers the following treatment areas:
Respiratory
Anti-Epileptic
Urinary Tract
Iron
Liver
Gastro Intestinal
Pain and Inflamation
* In terms of South African legislation, scheduled products may not be marketed to the public and the brands have therefore not been mentioned on this website
The OTC product range encompasses the following treatment areas and products:
Laxatives – Agiolax® and Agiobulk®
Tranquiliser – Biral®
Pain and Inflammation – Empaped®, Reparil®, Dona®
Vitamin and Mineral – Emvit®, Emvit®.M, Emvit® Cal-D3, Magnesit®
Iron – Ferrimed®
Sun care – Piz Buin®
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie,…
Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can…
The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He…
The owner of Altis Biologics, Nick Duneas, illustrates the significance of the company’s flagship product, the Altis Osteogenic Bone Matrix (OBM) and how the company plans to commercialize the injectable bone…
The managing director of Trinity Pharma, Gaby Simaan (Jnr) depicts Trinity’s evolution from a regulatory consultancy into a fully commercialized pharmaceutical company, and how their unique position in the private…
The managing director of Galderma South Africa, Jenny Wright reveals the importance of the dermatology sector within the country’s healthcare system, as well as the role Galderma is playing in…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
The Head of the Department of Medicine at the Faculty of Health Science at the University of Cape Town reveals how their role is not only in training people to…
The managing director of Adcock Ingram’s prescription business, Ashley Pearce highlights the division’s strategic placement within the group’s overall activities, and how he plans on leveraging partnerships with various multinationals,…
The general manager of Ferring South Africa, Mercia Van Zyl discusses the company’s ambitious plans for the future under the slogan ‘People come first’, the placement of fertility under the…
The CEO of IPASA reveals how over the last ten months the priority has been to reach out to different stakeholders, rebuilding trust with the department of health, with patients…
The director of MRA Regulatory Consultants, Henriette Vienings reveals the important role they play in helping pharmaceutical companies navigate South Africa’s regulatory environment, as well as the importance of the…
See our Cookie Privacy Policy Here
